Home Prescription Drugs Tags

View the Latest: Prescription Drugs

Filter

List Grid

451 - 460 of 797 Results

  • Health Care Costs Survey – Toplines

    Poll Finding

    This document includes the toplines from the joint USA Today/Kaiser/Harvard School of Public Health survey exploring Americans’ views on health care costs. Survey Toplines (.pdf)

  • Toplines: December 2005 Kaiser Health Poll Report

    Poll Finding

    Toplines: December 2005 Kaiser Health Poll Report These toplines provide the complete survey questions and responses to the December 2005 Kaiser Health Poll Report Survey, a bimonthly survey designed to provide key tracking information on public opinion about health care topics. The survey includes a series of questions on seniors' views of the new Medicare prescription drug benefit. Survey Toplines (.pdf)

  • NPR/Kaiser/Harvard Survey – Children’s OTC Cold Medicines: The Public, and Parents, Weigh In: Summary and Chartpack

    Poll Finding

    This summary and chartpack provides an overview of the results of a November 2007 survey conducted jointly by NPR, the Kaiser Family Foundation, and the Harvard School of Public Health on the public’s views of over-the-counter children’s cold and cough medications in the wake of recent concerns regarding their safety and effectiveness. A nationally representative sample of 1,522 adults, including an oversample of parents with young children, participated in telephone interviews from Nov. 15-25. The…

  • The Obama Administration’s 2010 Call Letter for Medicare Advantage and Prescription Drug Plans: Implications for Beneficiaries

    Issue Brief

    On March 30, 2009, the Centers for Medicare & Medicaid Services issued the 2010 “call letter,” which functions as a request for proposals to private health insurers and organizations that want to sponsor Medicare Advantage Plans or Medicare Prescription Drug Plans. This issue brief reviews the call letter — the first issued by the Obama Administration — and examines the implications for beneficiaries of some of the proposed changes, including its emphasis on accountability of health plan sponsors, promoting…

  • A Prescription Drug Benefit in Medicare: Implications for Medicaid and Low-Income Medicare Beneficiaries

    Issue Brief

    The Senate and House of Representatives each approved legislation in June of 2003 that would establish outpatient prescription drug coverage for Medicare beneficiaries as part of Medicare program reform. Among the key differences in the House and Senate bills that still must be addressed are the treatment of Medicaid beneficiaries and the structure of low-income subsidy programs. The way in which these issues are resolved will have major implications for Medicaid beneficiaries, other low-income individuals,…

  • The “Clawback:” State Financing of Medicare Drug Coverage

    Issue Brief

    This issue paper describes the origins of the clawback, the formula by which each state’s clawback amount is calculated, and the clawback’s implications for states and for low-income Medicare beneficiaries. Issue Paper (.pdf)

  • Six Months ahead of the Midterm Elections, Democratic and Republican Voters’ Views about President Trump Outweigh their Views on Issues, Including Health Care

    News Release

    Who are the “Health Care Voters”? Mostly Women, and Mostly Planning to Vote Democratic As primary season for the 2018 midterm elections heats up, the latest Kaiser Family Foundation poll suggests the elections are shaping up more as a referendum on President Trump than on health care or any other issue. When asked what will make the biggest difference in how they vote in the Congressional elections, larger shares of Democrats and Republicans cite candidates’…

  • Resources on Dual Eligibles and Issues Related to Their Transition to the New Medicare Drug Benefit

    Event Date:
    Event

    With the new Medicare prescription drug benefit available as of January 1, 2006, over 6 million low-income seniors and people with disabilities who are enrolled in both Medicaid and Medicare—also known as dual eligibles—have been transitioned from Medicaid drug coverage to new Medicare drug plans. While there are many policy issues related to the overall establishment of the new drug benefit, the mandatory transition of dual eligibles has created a special set of challenges for…